sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022

Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh...

Home / Categories / Healthcare
Asia-Pacific In-Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycles) and End Users (Fertility Clinics, Hospitals, Surgical Centres, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022
Asia-Pacific In-Vitro Fertilization (IVF) Services...
Report Code
RO1/113/1105

Publish Date
01/Dec/2016

Pages
235
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Coverage and limitations
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 ASIA-PACIFIC IVF MARKET ANALYSIS

3.1 Market definition and scope
3.2 Overview
3.3 Drivers

3.3.1 Delay in family planning reduces chances of conception
3.3.2 Decline in birth rate
3.3.3 Emotional problems

3.4 Restraints
3.5 Asia-Pacific embryo transfer market, by Country
3.6 Asia-Pacific embryo transfer market by Cycle Types
3.7 Asia-Pacific embryo transfer market by End Users
3.8 Company Profile

3.8.1 Thermo Fisher Scientific, Inc.
3.8.2 Merck KGaA

CHAPTER 4 INDIA EMBRYO TRANSFER MARKET

4.1 Overview
4.2 India Embryo Transfer Market by End Users

4.2.1 Fertility clinics
4.2.2 Hospitals
4.2.3 Surgical centers
4.2.4 Clinical research institutes

4.3 India IVF Market by Cycle Type

4.3.1 Fresh IVF cycles (non-donor)
4.3.2 Thawed IVF cycles (non-donor)
4.3.3 Donor egg IVF cycles

4.4 Drivers
4.5 Restraints
4.6 Regulatory issues, legislations, and authorities
4.7 Insurance reimbursement scenario
4.8 Company/Hospitals/Clinics Profile

4.8.1 Sun Pharmaceutical Industries Ltd.
4.8.2 Trivector Origio Scientific Pvt. Ltd
4.8.3 Lab IVF Asia Pte. Ltd.
4.8.4 LG Life Sciences.
4.8.5 Cadila Healthcare Ltd. (Zydus Cadila group)
4.8.6 Bourn Hall Clinic
4.8.7 Morpheus IVF Fertility Center
4.8.8 Southend Fertility and IVF Centre
4.8.9 Nova IVI Fertility
4.8.10 Bloom Fertility Center
4.8.11 Manipal Ankur
4.8.12 Cloudnine

CHAPTER 5 CHINA EMBRYO TRANSFER MARKET

5.1 Overview
5.2 China Embryo Transfer Market by End Users

5.2.1 Fertility clinics
5.2.2 Hospitals
5.2.3 Surgical centers
5.2.4 Clinical research institutes

5.3 China IVF Market by Cycle Type

5.3.1 Fresh IVF cycles (non-donor)
5.3.2 Thawed IVF cycles (non-donor)
5.3.3 Donor egg IVF cycles

5.4 Drivers

5.4.1 Increased rate of infertility
5.4.2 Change in lifestyle

5.5 Restraints

5.5.1 Cost of living

5.6 Regulatory issues, legislations, and authorities
5.7 Insurance reimbursement scenario
5.8 Company/Hospitals/Clinics Profile

5.8.1 Cook Medical, Inc.
5.8.2 Vitrolife AB
5.8.3 Centre for Reproductive Medicine
5.8.4 Reproductive & Genetic Hospital Citic-Xiangya
5.8.5 Shenyang International Hospital
5.8.6 Shandong Provincial Hospital

CHAPTER 6 JAPAN EMBRYO TRANSFER MARKET

6.1 Overview
6.2 Japan Embryo Transfer Market by End Users

6.2.1 Fertility clinics
6.2.2 Hospitals
6.2.3 Surgical centers
6.2.4 Clinical research institutes

6.3 Japan IVF Market by Cycle Type

6.3.1 Fresh IVF cycles (non-donor)
6.3.2 Thawed IVF cycles (non-donor)

6.4 Drivers
6.5 Restraints
6.6 Regulatory issues, legislations, and authorities
6.7 Insurance reimbursement scenario
6.8 Company/Hospitals/Clinics Profile

6.8.1 Merck KGaA
6.8.2 IVF Namba Clinic
6.8.3 Iwaki Womens Clinic
6.8.4 Sanno Hospital

CHAPTER 7 AUSTRALIA EMBRYO TRANSFER MARKET

7.1 Overview
7.2 Australia Embryo Transfer Market by End Users

7.2.1 Fertility clinics
7.2.2 Hospitals
7.2.3 Surgical centers
7.2.4 Clinical research institutes

7.3 Australia IVF Market by Cycle Type

7.3.1 Fresh IVF cycles (non-donor)
7.3.2 Thawed IVF cycles (non-donor)

7.4 Drivers
7.5 Restraints

7.5.1 Emotional and physical stress
7.5.2 No guarantee
7.5.3 Surplus embryos

7.6 Regulatory issues, legislations, and authorities

7.6.1 Common Law
7.6.2 Legislative responses to IVF
7.6.3 Non-legislative regulation for the practice of IVF

7.7 Insurance reimbursement scenario
7.8 Company/Hospitals/Clinics Profile

7.8.1 Genea Biomedx
7.8.2 Thermo Fisher Scientific, Inc.
7.8.3 Virtus Health
7.8.4 Monash IVF
7.8.5 City Fertility
7.8.6 Flinders Fertility

CHAPTER 8 NEW ZEALAND EMBRYO TRANSFER MARKET

8.1 Overview
8.2 New Zealand Embryo Transfer Market by End Users

8.2.1 Fertility clinics
8.2.2 Hospitals
8.2.3 Surgical centers
8.2.4 Clinical research institutes

8.3 New Zealand IVF Market by Cycle Type

8.3.1 Fresh IVF cycles (non-donor)
8.3.2 Thawed IVF cycles (non-donor)
8.3.3 Donor egg IVF cycles

8.4 Drivers
8.5 Restraints
8.6 Regulatory issues, legislations, and authorities
8.7 Insurance reimbursement scenario
8.8 Hospitals/Clinics Profile

8.8.1 Fertility Associates
8.8.2 Fertility Plus
8.8.3 Reporomed

CHAPTER 9 KOREA EMBRYO TRANSFER MARKET

9.1 Overview
9.2 Korea Embryo Transfer Market by End Users

9.2.1 Fertility clinics
9.2.2 Hospitals
9.2.3 Surgical centers
9.2.4 Clinical research institutes

9.3 Korea IVF Market by Cycle Type

9.3.1 Fresh IVF cycles (non-donor)
9.3.2 Thawed IVF cycles (non-donor)
9.3.3 Donor egg IVF cycles

9.4 Drivers
9.5 Restraints
9.6 Regulatory issues, legislations, and authorities
9.7 Insurance reimbursement scenario
9.8 Hospitals/Clinics Profile

9.8.1 Cha General Hospital
9.8.2 Maria Fertility Hospital

CHAPTER 10 THAILAND EMBRYO TRANSFER MARKET

10.1 Overview
10.2 Thailand Embryo Transfer Market by End Users

10.2.1 Fertility clinics
10.2.2 Hospitals
10.2.3 Surgical centers
10.2.4 Clinical research institutes

10.3 Thailand IVF Market by Cycle Type

10.3.1 Fresh IVF cycles (non-donor)
10.3.2 Thawed IVF cycles (non-donor)
10.3.3 Donor egg IVF cycles

10.4 Drivers

10.4.1 Government initiatives
10.4.2 Surrogacy is economical as compared to developed countries
10.4.3 Boost in medical tourism

10.5 Restraints

10.5.1 Comparatively low success rate
10.5.2 Ethical issues in allowing gender selection

10.6 Regulatory issues, legislations, and authorities
10.7 Insurance reimbursement scenario
10.8 Hospitals/Clinics Profile

10.8.1 Bangkok Fertility Center
10.8.2 Siriraj Hospital
10.8.3 Ramathibodi Hospital
10.8.4 Perfect Woman Institute Piyavate Hospital
10.8.5 Jetanin Institute for Assisted Reproduction

CHAPTER 11 SINGAPORE EMBRYO TRANSFER MARKET

11.1 Overview
11.2 Singapore Embryo Transfer Market by End Users

11.2.1 Fertility clinics
11.2.2 Hospitals
11.2.3 Surgical centers
11.2.4 Clinical research institutes

11.3 Singapore IVF Market by Cycle Type

11.3.1 Fresh IVF cycles (non-donor)
11.3.2 Thawed IVF cycles (non-donor)

11.4 Drivers

11.4.1 Government funding and tax rebates for parents
11.4.2 Rising infertility rate
11.4.3 Increase in success rate

11.5 Restraints

11.5.1 High cost of IVF treatment and lower success rate

11.6 Regulatory issues, legislations, and authorities
11.7 Insurance reimbursement scenario
11.8 Company/Clinics Profile

11.8.1 Irvine Scientific
11.8.2 ESCO Technologies Inc.
11.8.3 Leica Microsystems GMBH
11.8.4 NUH IVF Centre
11.8.5 Mount Elizabeth Fertility Center
11.8.6 Thomson Fertility Centre
11.8.7 Raffles Fertility Centre

CHAPTER 12 MALAYSIAN EMBRYO TRANSFER MARKET

12.1 Overview
12.2 Malaysia Embryo Transfer Market by End Users

12.2.1 Fertility clinics
12.2.2 Hospitals
12.2.3 Surgical centers
12.2.4 Clinical research institutes

12.3 Malaysia IVF Market by Cycle Type

12.3.1 Fresh IVF cycles (non-donor)
12.3.2 Thawed IVF cycles (non-donor)
12.3.3 Donor egg IVF cycles

12.4 Drivers

12.4.1 Increase in government initiatives
12.4.2 Increase in the number of foreign patients
12.4.3 Decrease in rate of fertility and growing acceptability of IVF

12.5 Restraints
12.6 Regulatory issues, legislations, and authorities
12.7 Insurance reimbursement scenario
12.8 Clinics Profile

12.8.1 Subang Fertility Center
12.8.2 Concept Fertility Centre
12.8.3 TMC Fertility Center

CHAPTER 13 INDONESIAN EMBRYO TRANSFER MARKET

13.1 Overview
13.2 Indonesia Embryo Transfer Market by End Users

13.2.1 Fertility clinics
13.2.2 Hospitals
13.2.3 Surgical centers
13.2.4 Clinical research institutes

13.3 Indonesia IVF Market by Cycle Type

13.3.1 Fresh IVF cycles (non-donor)
13.3.2 Thawed IVF cycles (non-donor)
13.3.3 Donor egg IVF cycles

13.4 Drivers

13.4.1 Increase in disposable income
13.4.2 Advances in embryo transfer technology
13.4.3 Decline in fertility rate

13.5 Restraints

13.5.1 Physical and emotional impact due to low success rate

13.6 Regulatory issues, legislations, and authorities
13.7 Insurance reimbursement scenario
13.8 Clinics Profile

13.8.1 Morula IVF
13.8.2 Yasmin IVF
13.8.3 Aster Fertility Clinic
13.8.4 Fertility Centre, Siloam Hospitals Surabana

CHAPTER 14 PHILIPPINES EMBRYO TRANSFER MARKET

14.1 Overview
14.2 Philippines Embryo Transfer Market by End Users

14.2.1 Fertility clinics
14.2.2 Hospitals
14.2.3 Surgical centers
14.2.4 Clinical research institutes

14.3 Philippines IVF market by cycle type

14.3.1 Fresh IVF cycles (non-donor)
14.3.2 Thawed IVF cycles (non-donor)
14.3.3 Donor egg IVF cycles

14.4 Drivers

14.4.1 Improve the replacement population
14.4.2 Advancement in technology

14.5 Restraints

14.6 Regulatory issues, legislations, and authorities
14.7 Insurance reimbursement scenario

14.8 Clinic Profile

14.8.1 Victory Art Lab
14.8.2 CRM-MIA-Philippines

CHAPTER 15 VIETNAM EMBRYO TRANSFER MARKET

15.1 Overview
15.2 Vietnam Embryo Transfer Market by End Users

15.2.1 Fertility clinics
15.2.2 Hospitals
15.2.3 Surgical centers
15.2.4 Clinical research institutes

15.3 Vietnam IVF market by cycle type

15.3.1 Fresh IVF cycles (non-donor)
15.3.2 Thawed IVF cycles (non-donor)
15.3.3 Donor egg IVF cycles

15.4 Drivers

15.4.1 Decline in fertility rate
15.4.2 Reasonable cost and good success rate

15.5 Restraints
15.6 Regulatory issues, legislations, and authorities
15.7 Insurance reimbursement scenario
15.8 Hospital/Clinic Profile

15.8.1 IVF Lab Tu Du Hospital Vietnam
15.8.2 IVF Van Hanh
15.8.3 Sinh Hospital
15.8.4 Tu Du - Ho Chi Minh City Vietnam

CHAPTER 16 REST OF ASIA-PACIFIC EMBRYO TRANSFER MARKET

16.1 Overview
16.2 Rest of Asia-Pacific Embryo Transfer Market by End Users

16.2.1 Fertility clinics
16.2.2 Hospitals
16.2.3 Surgical centers
16.2.4 Clinical research institutes

16.3 Rest of Asia-Pacific IVF Market by Cycle Type

16.3.1 Fresh IVF cycles (non-donor)
16.3.2 Thawed IVF cycles (non-donor)
16.3.3 Donor egg IVF cycles

16.4 Drivers

16.4.1 Increase in disposable income
16.4.2 Advances in IVF technology
16.4.3 Decline in fertility rate

16.5 Restraints

16.5.1 Physical and emotional impact due to low success rate

16.6 Regulatory Issues, legislations, and Authorities
16.7 Insurance Reimbursement Scenario
16.8 Hospitals/Clinics Profile

16.8.1 Fertility Centre, Siloam Hospitals Surabana
16.8.2 CRM-MIA-Philippines
16.8.3 IVFAS

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com